Pasar al contenido principal

ESTUDIO DE LAS DINAMICAS NEURALES Y CONDUCTUALES ASOCIADAS A LAS RECOMPENSAS Y CASTIGOS EN LA ENFERMEDAD DE PARKINSON CON TRASTORNO DEL CONTROL DE IMPULSOS ASOCIADO

PID2021-127034OA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Addressing the sources of inter-subject variability in E-field parameters in anodal tDCS stimulation over motor cortical network

  • Franco-Rosado, Pablo
  • Callejón, M. Amparo
  • Reina-Tosina, Javier
  • Roa, Laura M.
  • Martín-Rodríguez, Juan Francisco
  • Mir, Pablo
Objetive: .Although transcranial direct current stimulation constitutes a non-invasive neuromodulation technique with promising results in a great variety of applications, its clinical implementation is compromised by the high inter-subject variability reported. This study aims to analyze the inter-subject variability in electric fields (E-fields) over regions of the cortical motor network under two electrode montages: the classical C3Fp2 and an alternative P3F3, which confines more the E-field over this region.Approach.Computational models of the head of 98 healthy subjects were developed to simulate the E-field under both montages. E-field parameters such as magnitude, focality and orientation were calculated over three regions of interest (ROI): M1S1, supplementary motor area (SMA) and preSMA. The role of anatomical characteristics as a source of inter-subject variability on E-field parameters and individualized stimulation intensity were addressed using linear mixed-effect models.Main results.P3F3 showed a more confined E-field distribution over M1S1 than C3Fp2; the latter elicited higher E-fields over supplementary motor areas. Both montages showed high inter-subject variability, especially for the normal component over C3Fp2. Skin, bone and CSF ROI volumes showed a negative association with E-field magnitude irrespective of montage. Grey matter volume and montage were the main sources of variability for focality. The curvature of gyri was found to be significantly associated with the variability of normal E-fields.Significance.Computational modeling proves useful in the assessment of E-field variability. Our simulations predict significant differences in E-field magnitude and focality for C3Fp2 and P3F3. However, anatomical characteristics were also found to be significant sources of E-field variability irrespective of electrode montage. The normal E-field component better captured the individual variability and low rate of responder subjects observed in experimental studies., This work was supported by the was supported by the Asociación Universitaria Iberoamericana de Postgrado (AUIP), Spanish Ministry of Science and Innovation (RTC2019-007150-1, PID2021-127034OA-I00), Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (ISCIII-FEDER) (PI16/01575, PI18/01898, PI19/01576, PI20/00613, PI21/01875, PI22/01704), Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía (CVI-02526, CTS-7685), Consejería de Salud y Bienestar Social de la Junta de Andalucía (PI-0471-2013, PE-0210-2018, PI-0459-2018, PE-0186-2019, PIN-0097-2020), Consejería de Transformación Económica, Industria, Conocimiento y Universidades de la Junta de Andalucía (PY20_00896, PY20_00903), OTOVIRT project (PIN-0097-2020) from Andalusian Government co-funded by FEDER and the Fundación Alicia Koplowitz. PMR is member of the European Reference Network for Rare Neurological Diseases (Project ID 739510). Acknowledgements to Sofia Rita Fernandes for her exhaustive review of this work., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cortical hypometabolism in Parkinson's disease is linked to cholinergic basal forebrain atrophy

  • Labrador, Miguel Ángel
  • Silva-Rodríguez, Jesús
  • Okkels, Niels
  • Muñoz-Delgado, Laura
  • Horsager, Jacob
  • Castro-Labrador, Sandra
  • Franco-Rosado, Pablo
  • Castellano-Guerrero, Ana María
  • Iglesias Camacho, Elena
  • San Eufrasio, Manuela
  • Macías García, Daniel
  • Jesús, Silvia
  • Adarmes-Gómez, Astrid
  • Ojeda, Elena
  • Carrillo, Fátima
  • Martín-Rodríguez, Juan Francisco
  • Roldán Lora, Florinda
  • García-Solís, David
  • Borghammer, Per
  • Mir, Pablo
  • Grothe, Michel J.
Cortical hypometabolism on FDG-PET is a well-established neuroimaging biomarker of cognitive impairment in Parkinson's disease (PD), but its pathophysiologic origins are incompletely understood. Cholinergic basal forebrain (cBF) degeneration is a prominent pathological feature of PD-related cognitive impairment and may contribute to cortical hypometabolism through cholinergic denervation of cortical projection areas. Here, we investigated in-vivo associations between subregional cBF volumes on 3T-MRI, cortical hypometabolism on [18F]FDG-PET, and cognitive deficits in a cohort of 95 PD participants with varying degrees of cognitive impairment. We further assessed the spatial correspondence of the cortical pattern of cBF-associated hypometabolism with the pattern of cholinergic denervation in PD as assessed by [18F]FEOBV-PET imaging of presynaptic cholinergic terminal density in a second cohort. Lower volume of the cortically-projecting posterior cBF, but not of the anterior cBF, was significantly associated with extensive neocortical hypometabolism [p(FDR) < 0.05], which mediated the association between cBF atrophy and cognitive impairment (mediated proportion: 43%, p < 0.001). In combined models, posterior cBF atrophy explained more variance in cortical hypometabolism (R2 = 0.26, p < 0.001) than local atrophy in the cortical areas themselves (R2 = 0.16, p = 0.01). Topographic correspondence analysis with the [18F]FEOBV-PET pattern revealed that cortical areas showing most pronounced cBF-associated hypometabolism correspond to those showing most severe cholinergic denervation in PD (Spearman's ρ = 0.57, p < 0.001). In conclusion, posterior cBF atrophy in PD is selectively associated with hypometabolism in denervated cortical target areas, which mediates the effect of cBF atrophy on cognitive impairment. These data provide first-time in-vivo evidence that cholinergic degeneration represents a principle pathological correlate of cortical hypometabolism underlying cognitive impairment in PD., This work was supported by the Spanish Ministry of Science and Innovation (RTC2019-007150-1, PID2021-127034OA-I00), the Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (ISCIII-FEDER) (PI16/01575, PI18/01898, PI19/01576, PI20/00613, PI21/01875, PI22/01704), the Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía (CVI-02526, CTS-7685), the Consejería de Salud y Bienestar Social de la Junta de Andalucía (PI-0471-2013, PE-0210-2018, PI-0459-2018, PE-0186-2019), the Consejería de Transformación Económica, Industria, Conocimiento y Universidades de la Junta de Andalucía (PY20_00896, P20_00903), and the Fundación Alicia Koplowitz. Several authors of this publication are members of the European Reference Network for Rare Neurological Diseases (project ID 739510). M.A.L.E. is supported by a PhD scholarship (VI-PPIT-US) from the University of Seville (USE-19094-G). J.S.R. is supported by the “Sara Borrell” program (CD21/00067) of the ISCIII-FEDER. M.J.G. is supported by the “Miguel Servet” program (CP19/00031) of the ISCIII-FEDER. N.O. is supported by the Danish Parkinson’s Disease Association and the Health Research Foundation of Central Denmark Region. L.M.D. is supported by the “Río Hortega” program (CM21/00051) of the ISCIII-FEDER. D.M.G. is supported by the “Juan Rodés” program (JR22/00073) of the ISCIII-FEDER., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Imaging biomarkers of cortical neurodegeneration underlying cognitive impairment in Parkinson's disease

  • Silva-Rodríguez, Jesús
  • Labrador, Miguel Ángel
  • Castro-Labrador, Sandra
  • Muñoz-Delgado, Laura
  • Franco-Rosado, Pablo
  • Castellano-Guerrero, Ana María
  • Macías García, Daniel
  • Jesús Maestre, Silvia
  • Adarmes-Gómez, Astrid
  • Carrillo, Fátima
  • Martín-Rodríguez, Juan Francisco
  • García-Solís, David
  • Roldán Lora, Florinda
  • Mir, Pablo
  • Grothe, Michel J.
[Purpose] Imaging biomarkers bear great promise for improving the diagnosis and prognosis of cognitive impairment in Parkinson’s disease (PD). We compared the ability of three commonly used neuroimaging modalities to detect cortical changes in PD patients with mild cognitive impairment (PD-MCI) and dementia (PDD)., [Methods] 53 cognitively normal PD patients (PD-CN), 32 PD-MCI, and 35 PDD underwent concurrent structural MRI (sMRI), diffusion-weighted MRI (dMRI), and [18F]FDG PET. We extracted grey matter volumes (sMRI), mean diffusivity (MD, dMRI), and standardized uptake value ratios ([18F]FDG PET) for 52 cortical regions included in a neuroanatomical atlas. We assessed group differences using ANCOVA models and further applied a cross-validated machine learning approach to identify the modality-specific brain regions that are most indicative of dementia status and assessed their diagnostic accuracy for group separation using receiver operating characteristic analyses., [Results] In sMRI, atrophy of temporal and posterior-parietal areas allowed separating PDD from PD-CN (AUC = 0.77 ± 0.07), but diagnostic accuracy was poor for separating PD-MCI from PD-CN (0.57 ± 0.10). dMRI showed most pronounced diffusivity changes in the medial temporal lobe, which provided excellent diagnostic performance for PDD (AUC = 0.87 ± 0.06), and a more modest but still significant performance for PD-MCI (AUC = 0.71 ± 0.09). Finally, [18F]FDG PET revealed pronounced hypometabolism in posterior-occipital regions, which provided the highest diagnostic accuracies for both PDD (AUC = 0.89 ± 0.05) and PD-MCI (AUC = 0.78 ± 0.05). In statistical comparisons, both [18F]FDG PET (p < 0.001) and dMRI (p < 0.031) outperformed sMRI for detecting PDD and PD-MCI., [Conclusion] Among the tested modalities, [18F]FDG PET was most accurate for detecting cortical changes associated with cognitive impairment in PD, especially at early stages. Diffusion measurements may represent a promising MRI-based alternative., Funding for open access publishing: Universidad de Sevilla/CBUA. This work was supported by the Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (ISCIII-FEDER) (PI19/01576, PI20/00613), the Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía (CVI-02526, CTS-7685), the Consejería de Salud y Familias de la Junta de Andalucía (PI-0046-2021), and the MCIN/AEI (PID2021-127034OA-I00). JSR was supported by the “Sara Borrell” program from ISCIII-FEDER (CD21/00067), MALE was supported by a PhD scholarship (VI-PPIT-US) from the University of Seville (USE-19094-G), and MJG was supported by the “Miguel Servet” program from ISCIII-FEDER (CP19/00031)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

EEG changes induced by dopamine replacement therapy in Parkinson’s disease with impulse control disorders

  • Martín-Rodríguez, Juan Francisco
  • Iglesias Camacho, Elena
  • Gómez-Campos, Francisco Javier
  • Franco-Rosado, Pablo
  • Garrote-Espina, Lorena
  • Muñoz-Delgado, Laura
  • Jesús Maestre, Silvia
  • Macías García, Daniel
  • Adarmes-Gómez, Astrid
  • Carrillo, Fátima
  • Mir, Pablo
[Objectives] Impulse control disorders (ICDs) are a common complication in Parkinson’s disease (PD) patients undergoing dopaminergic therapy. Although neurophysiological markers of ICDs have been identified, the effect of dopaminergic therapy on these markers is not fully understood. This study investigates the effect of dopaminergic therapy on EEG oscillatory activity in PD patients with and without ICDs., [Methods] A total of 26 PD patients—14 with ICDs (PD + ICD) and 12 healthy controls (HC)—participated. EEG recordings were obtained during regular dopamine therapy (ON) and after overnight withdrawal (OFF). Spectral analysis assessed group differences in EEG activity and the effect of dopaminergic treatment, while correlations between neurophysiological parameters and impulsivity were analysed., [Results] Results showed increased theta power (4–7.5 Hz) in the fronto-central regions of PD+ICD patients in the OFF state compared to healthy controls. In the ON state, PD+ICD patients showed increased frontal high beta (21–30 Hz) and central alpha (8–12 Hz) activity. Frontal beta activity correlated with impulsivity, independent of treatment dose., [Conclusions] PD + ICD patients show distinct neurophysiological profiles influenced by dopaminergic treatment, highlighting the modulatory effect of therapy on EEG patterns in these patients., [Significance] This study highlights the modulatory effect of dopaminergic therapy on EEG oscillatory patterns in PD patients with ICDs., We are very grateful to the individuals who participated in this study. This work was supported by a Grant PID2021-127034OA-I00 funded by MCIN/AEI/10.13039/501100011033 and, by “ERDF A way of making Europe”, the Spanish Ministry of Science and Innovation (RTC2019-007150-1), the Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (ISCIII-FEDER) (PI16/01575, PI18/01898, PI19/01576, PI22/01704), the Fundación Progreso y Salud (PI-0055-2014), the Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía (CVI-02526, CTS-7685), the Consejería de Salud y Bienestar Social de la Junta de Andalucía (PI-0471-2013, PE-0210-2018, PI-0459-2018, PE-0186-2019), the Consejería de Transformacion Economica, Industria, Conocimiento y Universidades de la Junta de Andalucía (PY20_00903), and the Fundacion Alicia Koplowitz. Several authors of this publication are members of the European Reference Network for Rare Neurological Diseases (project ID 739510). L.M.D. and P.M.R. are members of the COST Action IMMUPARKNET (CA21117). D.M.G. was supported by the “Juan Rodés” program [JR22/00073] from the Instituto de Salud Carlos III (ISCIII-FEDER)., Peer reviewed